HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

Philadelphia, PA, May 05, 2026 (GLOBE NEWSWIRE) -- HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into a definitive agreement to acquire Symphony Health Solutions Corporation, a commercial healthcare data business formerly part of ICON plc (NASDAQ: ICLR). The transaction is subject to customary closing conditions and is expected to close in May 2026.

GlobeNewsWire • May 5, 2026

Calamos Phineus Long/Short Fund: Q1 2026 Contributors And Detractors

L3Harris Technologies Inc. rallied as the Trump administration indicated a potential defense budget increase, which could drive meaningful upside to revenue and earnings estimates over the next few years. Regal Rexnord Corp. outperformed as its data center opportunity offered a new growth vector, with management disclosing substantial orders tied to its integrated powertrain solution for power infrastructure. CACI International Inc. management distinguished the firm by raising estimates throughout a period of government spending uncertainty, demonstrating minimal exposure to the budget cuts weighing on its peers.

Seeking Alpha • May 5, 2026

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

DUBLIN--(BUSINESS WIRE)--ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results.

Business Wire • Apr 29, 2026

TLC International Equity Portfolio Q1 2026 Leaders And Laggards

The International Equity portfolio declined 6.5% gross during 1Q vs a 1.2% decline for the MSCI EAFE Index, as both sector exposure and stock selection were headwinds to relative performance. BAE Systems PLC shares returned 26% during 1Q'26, as the company is well positioned to benefit from defense spending growth across NATO member countries over the coming decade. Taiwan Semiconductor Manufacturing Company Limited continued to benefit from attractive demand fundamentals and raised its revenue outlook after consistently exceeding sales expectations in prior quarters.

Seeking Alpha • Apr 29, 2026

Invesco EQV International Equity Fund Q1 2026 Portfolio Review

Invesco EQV International Equity Fund trailed the index primarily due to stock selection in financials and industrials. Stock selection in financials and industrials, along with an underweight and stock selection in energy, detracted the most from relative return. Conversely, an underweight allocation in communication services and stock selection in consumer staples added to relative performance.

Seeking Alpha • Apr 26, 2026

White Brook Capital Partners: Stocks We Believe Will Be Meaningful Contributors

ICON trades at a low double digit multiple of free cash flow, a fraction of its historical average and a price that materially underestimates the strength of their business. Growth and tumult in private credit, data center financing, and AI driven financial engineering products reinforce the necessity of S&P Global's services. Sanara Medtech continues to be an extremely favorable risk reward with increasing evidence of their product's efficacy recently released and a focus on increasing per hospital doctor penetration.

Seeking Alpha • Apr 23, 2026

Artisan Mid Cap Value Fund Q1 2026 Performance Review

Artisan Mid Cap Value Fund portfolio trailed the Russell Midcap® Value Index in Q1. Performance was weighed down by a market environment that continued to favor momentum-driven stocks, with less support for quality factors. Among the biggest decliners were ICON, Gartner and Pinterest, each of which dropped by 30% or more during the quarter. Our three largest new buys by position size were Brown & Brown, Veralto and IQVIA Holdings.

Seeking Alpha • Apr 15, 2026

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

DUBLIN & COLUMBIA, Md.--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,' connected site network model for clinical trials. The partnership will integrate ICON's global clinical trial solutions and services with Advarra's site CTMSs, eISF, an.

Business Wire • Mar 24, 2026

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ICON PLC (“ICON” or the “Company”) (NASDAQ: ICLR) for potential violations of the federal securities laws.

GlobeNewsWire • Mar 16, 2026

ICLR ALERT: Ongoing Investigation Into ICON Public Limited Company - Contact Levi & Korsinsky

New York, New York--(Newsfile Corp. - March 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company (NASDAQ: ICLR) ("ICON Public Limited Company") concerning potential violations of the federal securities laws. The magnitude of the single-day decline wiped out billions of dollars of shareholder value and represented one of the largest percentage drops in the CRO sector in recent years.

Newsfile Corp • Mar 16, 2026